Gene therapy and cement injection for restabilization of loosened hip prostheses

Research output: Contribution to journalArticle


  • JJ De Poorter
  • RC Hoeben
  • S Hogendoorn
  • J Ellis
  • WR Obermann
  • TWJ Huizinga
  • RGHH Nelissen

Colleges, School and Institutes


Loosening of orthopedic hip prostheses is an increasing health problem. In elderly patients with comorbidity, revision surgery may lead to high mortality rates. A less invasive surgical technique is therefore required to reduce these patient risks. To this end a percutaneous gene therapy approach was designed to destroy the periprosthetic loosening membrane, and enable refixing of the hip prosthesis with percutaneous bone cement injections under radiological guidance. In this phase 1/2 dose-escalating gene therapy clinical trial, 12 patients were treated. Toxicity and hip function variables were monitored up to 6 months posttreatment. All patients completed the study and no dose-limiting toxicity was observed. Improvement in walking distance, independence, and pain was demonstrated particularly in patients receiving 3 X 10(10) and 1 X 10(11) viral particles. Taken together, these data show that this gene therapy approach targeted at the interface membrane around a loosened hip prosthesis is a feasible treatment option for elderly patients for whom surgical intervention is not appropriate.


Original languageEnglish
Pages (from-to)83-95
Number of pages13
JournalHuman Gene Therapy
Issue number1
Publication statusPublished - 1 Jan 2008